0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Delivery System Technology Drug Market Research Report 2023
Published Date: October 2023
|
Report Code: QYRE-Auto-5M5462
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gene Delivery System Technology Drug Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Gene Delivery System Technology Drug Market Research Report 2023

Code: QYRE-Auto-5M5462
Report
October 2023
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gene Delivery System Technology Drug Market Size

According to new survey, global Gene Delivery System Technology Drug market is projected to reach US$ 34850 million in 2029, increasing from US$ 9063 million in 2022, with the CAGR of 20.2% during the period of 2023 to 2029.

Gene Delivery System Technology Drug Market

Gene Delivery System Technology Drug Market

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gene Delivery System Technology Drug market research.
The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gene Delivery System Technology Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Gene Delivery System Technology Drug Market Report

Report Metric Details
Report Name Gene Delivery System Technology Drug Market
Accounted market size in 2022 US$ 9063 million
Forecasted market size in 2029 US$ 34850 million
CAGR 20.2%
Base Year 2022
Forecasted years 2023 - 2029
Segment by Type
  • Viral Gene Delivery System
  • Non-viral Gene Delivery System
Segment by Application
  • Neurological Diseases
  • Cancer
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Gene Delivery System Technology Drug Market growing?

Ans: The Gene Delivery System Technology Drug Market witnessing a CAGR of 20.2% during the forecast period 2023-2029.

What is the Gene Delivery System Technology Drug Market size in 2029?

Ans: The Gene Delivery System Technology Drug Market size in 2029 will be US$ 34850 million.

Who are the main players in the Gene Delivery System Technology Drug Market report?

Ans: The main players in the Gene Delivery System Technology Drug Market are Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute

What are the Application segmentation covered in the Gene Delivery System Technology Drug Market report?

Ans: The Applications covered in the Gene Delivery System Technology Drug Market report are Neurological Diseases, Cancer, Other

What are the Type segmentation covered in the Gene Delivery System Technology Drug Market report?

Ans: The Types covered in the Gene Delivery System Technology Drug Market report are Viral Gene Delivery System, Non-viral Gene Delivery System

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Delivery System Technology Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.3 Market by Application
1.3.1 Global Gene Delivery System Technology Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Delivery System Technology Drug Market Perspective (2018-2029)
2.2 Gene Delivery System Technology Drug Growth Trends by Region
2.2.1 Global Gene Delivery System Technology Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Delivery System Technology Drug Historic Market Size by Region (2018-2023)
2.2.3 Gene Delivery System Technology Drug Forecasted Market Size by Region (2024-2029)
2.3 Gene Delivery System Technology Drug Market Dynamics
2.3.1 Gene Delivery System Technology Drug Industry Trends
2.3.2 Gene Delivery System Technology Drug Market Drivers
2.3.3 Gene Delivery System Technology Drug Market Challenges
2.3.4 Gene Delivery System Technology Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Delivery System Technology Drug Players by Revenue
3.1.1 Global Top Gene Delivery System Technology Drug Players by Revenue (2018-2023)
3.1.2 Global Gene Delivery System Technology Drug Revenue Market Share by Players (2018-2023)
3.2 Global Gene Delivery System Technology Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Delivery System Technology Drug Revenue
3.4 Global Gene Delivery System Technology Drug Market Concentration Ratio
3.4.1 Global Gene Delivery System Technology Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Delivery System Technology Drug Revenue in 2022
3.5 Gene Delivery System Technology Drug Key Players Head office and Area Served
3.6 Key Players Gene Delivery System Technology Drug Product Solution and Service
3.7 Date of Enter into Gene Delivery System Technology Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Delivery System Technology Drug Breakdown Data by Type
4.1 Global Gene Delivery System Technology Drug Historic Market Size by Type (2018-2023)
4.2 Global Gene Delivery System Technology Drug Forecasted Market Size by Type (2024-2029)
5 Gene Delivery System Technology Drug Breakdown Data by Application
5.1 Global Gene Delivery System Technology Drug Historic Market Size by Application (2018-2023)
5.2 Global Gene Delivery System Technology Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gene Delivery System Technology Drug Market Size (2018-2029)
6.2 North America Gene Delivery System Technology Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gene Delivery System Technology Drug Market Size by Country (2018-2023)
6.4 North America Gene Delivery System Technology Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Delivery System Technology Drug Market Size (2018-2029)
7.2 Europe Gene Delivery System Technology Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gene Delivery System Technology Drug Market Size by Country (2018-2023)
7.4 Europe Gene Delivery System Technology Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Delivery System Technology Drug Market Size (2018-2029)
8.2 Asia-Pacific Gene Delivery System Technology Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gene Delivery System Technology Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Gene Delivery System Technology Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Delivery System Technology Drug Market Size (2018-2029)
9.2 Latin America Gene Delivery System Technology Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gene Delivery System Technology Drug Market Size by Country (2018-2023)
9.4 Latin America Gene Delivery System Technology Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Delivery System Technology Drug Market Size (2018-2029)
10.2 Middle East & Africa Gene Delivery System Technology Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gene Delivery System Technology Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Gene Delivery System Technology Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Delivery System Technology Drug Introduction
11.1.4 Biogen Revenue in Gene Delivery System Technology Drug Business (2018-2023)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Delivery System Technology Drug Introduction
11.2.4 Novartis Revenue in Gene Delivery System Technology Drug Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Detail
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene Delivery System Technology Drug Introduction
11.3.4 Gilead Sciences Revenue in Gene Delivery System Technology Drug Business (2018-2023)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Detail
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene Delivery System Technology Drug Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene Delivery System Technology Drug Business (2018-2023)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Detail
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene Delivery System Technology Drug Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene Delivery System Technology Drug Business (2018-2023)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene Delivery System Technology Drug Introduction
11.6.4 Amgen Revenue in Gene Delivery System Technology Drug Business (2018-2023)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Detail
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene Delivery System Technology Drug Introduction
11.7.4 Spark Therapeutics Revenue in Gene Delivery System Technology Drug Business (2018-2023)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Detail
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene Delivery System Technology Drug Introduction
11.8.4 Akcea Therapeutics Revenue in Gene Delivery System Technology Drug Business (2018-2023)
11.8.5 Akcea Therapeutics Recent Development
11.9 bluebird bio
11.9.1 bluebird bio Company Detail
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Gene Delivery System Technology Drug Introduction
11.9.4 bluebird bio Revenue in Gene Delivery System Technology Drug Business (2018-2023)
11.9.5 bluebird bio Recent Development
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Detail
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Gene Delivery System Technology Drug Introduction
11.10.4 Sunway Biotech Revenue in Gene Delivery System Technology Drug Business (2018-2023)
11.10.5 Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Detail
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Gene Delivery System Technology Drug Introduction
11.11.4 SIBIONO Revenue in Gene Delivery System Technology Drug Business (2018-2023)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Detail
11.12.2 AnGes Business Overview
11.12.3 AnGes Gene Delivery System Technology Drug Introduction
11.12.4 AnGes Revenue in Gene Delivery System Technology Drug Business (2018-2023)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Detail
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Gene Delivery System Technology Drug Introduction
11.13.4 Orchard Therapeutics Revenue in Gene Delivery System Technology Drug Business (2018-2023)
11.13.5 Orchard Therapeutics Recent Development
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Detail
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Gene Delivery System Technology Drug Introduction
11.14.4 Human Stem Cells Institute Revenue in Gene Delivery System Technology Drug Business (2018-2023)
11.14.5 Human Stem Cells Institute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Gene Delivery System Technology Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Viral Gene Delivery System
    Table 3. Key Players of Non-viral Gene Delivery System
    Table 4. Global Gene Delivery System Technology Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 5. Global Gene Delivery System Technology Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Gene Delivery System Technology Drug Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Gene Delivery System Technology Drug Market Share by Region (2018-2023)
    Table 8. Global Gene Delivery System Technology Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Gene Delivery System Technology Drug Market Share by Region (2024-2029)
    Table 10. Gene Delivery System Technology Drug Market Trends
    Table 11. Gene Delivery System Technology Drug Market Drivers
    Table 12. Gene Delivery System Technology Drug Market Challenges
    Table 13. Gene Delivery System Technology Drug Market Restraints
    Table 14. Global Gene Delivery System Technology Drug Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Gene Delivery System Technology Drug Market Share by Players (2018-2023)
    Table 16. Global Top Gene Delivery System Technology Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Delivery System Technology Drug as of 2022)
    Table 17. Ranking of Global Top Gene Delivery System Technology Drug Companies by Revenue (US$ Million) in 2022
    Table 18. Global 5 Largest Players Market Share by Gene Delivery System Technology Drug Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Gene Delivery System Technology Drug Product Solution and Service
    Table 21. Date of Enter into Gene Delivery System Technology Drug Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Gene Delivery System Technology Drug Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Gene Delivery System Technology Drug Revenue Market Share by Type (2018-2023)
    Table 25. Global Gene Delivery System Technology Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Gene Delivery System Technology Drug Revenue Market Share by Type (2024-2029)
    Table 27. Global Gene Delivery System Technology Drug Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Gene Delivery System Technology Drug Revenue Market Share by Application (2018-2023)
    Table 29. Global Gene Delivery System Technology Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Gene Delivery System Technology Drug Revenue Market Share by Application (2024-2029)
    Table 31. North America Gene Delivery System Technology Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 32. North America Gene Delivery System Technology Drug Market Size by Country (2018-2023) & (US$ Million)
    Table 33. North America Gene Delivery System Technology Drug Market Size by Country (2024-2029) & (US$ Million)
    Table 34. Europe Gene Delivery System Technology Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. Europe Gene Delivery System Technology Drug Market Size by Country (2018-2023) & (US$ Million)
    Table 36. Europe Gene Delivery System Technology Drug Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Asia-Pacific Gene Delivery System Technology Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Asia-Pacific Gene Delivery System Technology Drug Market Size by Region (2018-2023) & (US$ Million)
    Table 39. Asia-Pacific Gene Delivery System Technology Drug Market Size by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Gene Delivery System Technology Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Latin America Gene Delivery System Technology Drug Market Size by Country (2018-2023) & (US$ Million)
    Table 42. Latin America Gene Delivery System Technology Drug Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Middle East & Africa Gene Delivery System Technology Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Middle East & Africa Gene Delivery System Technology Drug Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Middle East & Africa Gene Delivery System Technology Drug Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Biogen Company Detail
    Table 47. Biogen Business Overview
    Table 48. Biogen Gene Delivery System Technology Drug Product
    Table 49. Biogen Revenue in Gene Delivery System Technology Drug Business (2018-2023) & (US$ Million)
    Table 50. Biogen Recent Development
    Table 51. Novartis Company Detail
    Table 52. Novartis Business Overview
    Table 53. Novartis Gene Delivery System Technology Drug Product
    Table 54. Novartis Revenue in Gene Delivery System Technology Drug Business (2018-2023) & (US$ Million)
    Table 55. Novartis Recent Development
    Table 56. Gilead Sciences Company Detail
    Table 57. Gilead Sciences Business Overview
    Table 58. Gilead Sciences Gene Delivery System Technology Drug Product
    Table 59. Gilead Sciences Revenue in Gene Delivery System Technology Drug Business (2018-2023) & (US$ Million)
    Table 60. Gilead Sciences Recent Development
    Table 61. Sarepta Therapeutics Company Detail
    Table 62. Sarepta Therapeutics Business Overview
    Table 63. Sarepta Therapeutics Gene Delivery System Technology Drug Product
    Table 64. Sarepta Therapeutics Revenue in Gene Delivery System Technology Drug Business (2018-2023) & (US$ Million)
    Table 65. Sarepta Therapeutics Recent Development
    Table 66. Alnylam Pharmaceuticals Company Detail
    Table 67. Alnylam Pharmaceuticals Business Overview
    Table 68. Alnylam Pharmaceuticals Gene Delivery System Technology Drug Product
    Table 69. Alnylam Pharmaceuticals Revenue in Gene Delivery System Technology Drug Business (2018-2023) & (US$ Million)
    Table 70. Alnylam Pharmaceuticals Recent Development
    Table 71. Amgen Company Detail
    Table 72. Amgen Business Overview
    Table 73. Amgen Gene Delivery System Technology Drug Product
    Table 74. Amgen Revenue in Gene Delivery System Technology Drug Business (2018-2023) & (US$ Million)
    Table 75. Amgen Recent Development
    Table 76. Spark Therapeutics Company Detail
    Table 77. Spark Therapeutics Business Overview
    Table 78. Spark Therapeutics Gene Delivery System Technology Drug Product
    Table 79. Spark Therapeutics Revenue in Gene Delivery System Technology Drug Business (2018-2023) & (US$ Million)
    Table 80. Spark Therapeutics Recent Development
    Table 81. Akcea Therapeutics Company Detail
    Table 82. Akcea Therapeutics Business Overview
    Table 83. Akcea Therapeutics Gene Delivery System Technology Drug Product
    Table 84. Akcea Therapeutics Revenue in Gene Delivery System Technology Drug Business (2018-2023) & (US$ Million)
    Table 85. Akcea Therapeutics Recent Development
    Table 86. bluebird bio Company Detail
    Table 87. bluebird bio Business Overview
    Table 88. bluebird bio Gene Delivery System Technology Drug Product
    Table 89. bluebird bio Revenue in Gene Delivery System Technology Drug Business (2018-2023) & (US$ Million)
    Table 90. bluebird bio Recent Development
    Table 91. Sunway Biotech Company Detail
    Table 92. Sunway Biotech Business Overview
    Table 93. Sunway Biotech Gene Delivery System Technology Drug Product
    Table 94. Sunway Biotech Revenue in Gene Delivery System Technology Drug Business (2018-2023) & (US$ Million)
    Table 95. Sunway Biotech Recent Development
    Table 96. SIBIONO Company Detail
    Table 97. SIBIONO Business Overview
    Table 98. SIBIONO Gene Delivery System Technology Drug Product
    Table 99. SIBIONO Revenue in Gene Delivery System Technology Drug Business (2018-2023) & (US$ Million)
    Table 100. SIBIONO Recent Development
    Table 101. AnGes Company Detail
    Table 102. AnGes Business Overview
    Table 103. AnGes Gene Delivery System Technology Drug Product
    Table 104. AnGes Revenue in Gene Delivery System Technology Drug Business (2018-2023) & (US$ Million)
    Table 105. AnGes Recent Development
    Table 106. Orchard Therapeutics Company Detail
    Table 107. Orchard Therapeutics Business Overview
    Table 108. Orchard Therapeutics Gene Delivery System Technology Drug Product
    Table 109. Orchard Therapeutics Revenue in Gene Delivery System Technology Drug Business (2018-2023) & (US$ Million)
    Table 110. Orchard Therapeutics Recent Development
    Table 111. Human Stem Cells Institute Company Detail
    Table 112. Human Stem Cells Institute Business Overview
    Table 113. Human Stem Cells Institute Gene Delivery System Technology Drug Product
    Table 114. Human Stem Cells Institute Revenue in Gene Delivery System Technology Drug Business (2018-2023) & (US$ Million)
    Table 115. Human Stem Cells Institute Recent Development
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gene Delivery System Technology Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Gene Delivery System Technology Drug Market Share by Type: 2022 VS 2029
    Figure 3. Viral Gene Delivery System Features
    Figure 4. Non-viral Gene Delivery System Features
    Figure 5. Global Gene Delivery System Technology Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 6. Global Gene Delivery System Technology Drug Market Share by Application: 2022 VS 2029
    Figure 7. Neurological Diseases Case Studies
    Figure 8. Cancer Case Studies
    Figure 9. Other Case Studies
    Figure 10. Gene Delivery System Technology Drug Report Years Considered
    Figure 11. Global Gene Delivery System Technology Drug Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 12. Global Gene Delivery System Technology Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Gene Delivery System Technology Drug Market Share by Region: 2022 VS 2029
    Figure 14. Global Gene Delivery System Technology Drug Market Share by Players in 2022
    Figure 15. Global Top Gene Delivery System Technology Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Delivery System Technology Drug as of 2022)
    Figure 16. The Top 10 and 5 Players Market Share by Gene Delivery System Technology Drug Revenue in 2022
    Figure 17. North America Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 18. North America Gene Delivery System Technology Drug Market Share by Country (2018-2029)
    Figure 19. United States Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. Canada Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Europe Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Gene Delivery System Technology Drug Market Share by Country (2018-2029)
    Figure 23. Germany Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. France Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. U.K. Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Italy Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Russia Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Nordic Countries Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Asia-Pacific Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Gene Delivery System Technology Drug Market Share by Region (2018-2029)
    Figure 31. China Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Japan Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. South Korea Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Southeast Asia Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. India Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Australia Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Latin America Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Gene Delivery System Technology Drug Market Share by Country (2018-2029)
    Figure 39. Mexico Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Brazil Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Middle East & Africa Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Gene Delivery System Technology Drug Market Share by Country (2018-2029)
    Figure 43. Turkey Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Saudi Arabia Gene Delivery System Technology Drug Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Biogen Revenue Growth Rate in Gene Delivery System Technology Drug Business (2018-2023)
    Figure 46. Novartis Revenue Growth Rate in Gene Delivery System Technology Drug Business (2018-2023)
    Figure 47. Gilead Sciences Revenue Growth Rate in Gene Delivery System Technology Drug Business (2018-2023)
    Figure 48. Sarepta Therapeutics Revenue Growth Rate in Gene Delivery System Technology Drug Business (2018-2023)
    Figure 49. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Delivery System Technology Drug Business (2018-2023)
    Figure 50. Amgen Revenue Growth Rate in Gene Delivery System Technology Drug Business (2018-2023)
    Figure 51. Spark Therapeutics Revenue Growth Rate in Gene Delivery System Technology Drug Business (2018-2023)
    Figure 52. Akcea Therapeutics Revenue Growth Rate in Gene Delivery System Technology Drug Business (2018-2023)
    Figure 53. bluebird bio Revenue Growth Rate in Gene Delivery System Technology Drug Business (2018-2023)
    Figure 54. Sunway Biotech Revenue Growth Rate in Gene Delivery System Technology Drug Business (2018-2023)
    Figure 55. SIBIONO Revenue Growth Rate in Gene Delivery System Technology Drug Business (2018-2023)
    Figure 56. AnGes Revenue Growth Rate in Gene Delivery System Technology Drug Business (2018-2023)
    Figure 57. Orchard Therapeutics Revenue Growth Rate in Gene Delivery System Technology Drug Business (2018-2023)
    Figure 58. Human Stem Cells Institute Revenue Growth Rate in Gene Delivery System Technology Drug Business (2018-2023)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS